Chen Daniel ShinYu

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$2.1M

Insider Activity of Chen Daniel ShinYu

The largest sale of all time was on 2020-10-02 and amounted to 3660 shares of IGM Biosciences, Inc. for $269,010.

Biography of Chen Daniel ShinYu

No biography is available at this moment.

2021-07-06SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
1,886
0.0056%
$82.75$156,067-66.63%
2021-06-02SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
1,882
0.0055%
$79.15$148,960-38.44%
2021-05-26SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
888
0.0025%
$70.00$62,160-31.79%
2021-05-05SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
938
0.0029%
$62.32$58,452-10.42%
2021-04-06SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
2,444
0.0073%
$82.00$200,408-25.3%
2021-03-02SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
2,448
0.0074%
$90.25$220,932-25.45%
2021-02-03SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
2,452
0.0071%
$96.00$235,392-29.68%
2021-01-05SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
2,204
0.0066%
$79.25$174,667-7.63%
2020-12-08SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
2,438
0.0062%
$91.00$221,858-33.46%
2020-12-02SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
1,216
0.0039%
$63.15$76,796+23.05%
2020-11-04SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
1,210
0.0039%
$50.00$60,500+55.52%
2020-10-02SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
3,660
0.0119%
$73.50$269,010+8.15%
2020-09-18SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
1,218
0.0037%
$77.91$94,894-6.65%
2020-09-08SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
1,204
0.0039%
$50.20$60,441+56.01%
2020-08-27SaleIGM Biosciences, Inc.
IGMS
Chief Medical Officer
1,210
0.0041%
$45.13$54,602+79.91%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.